Amyloid-β diurnal pattern: Possible role of sleep in Alzheimer's disease pathogenesis

Neurobiology of Aging

Volumn 35, Issue SUPPL.2, 2014, Pages

  Lucey, Brendan P ^a   Bateman, Randall J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Diurnal pattern; Sleep

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; CIRCADIAN RHYTHM; COGNITIVE DEFECT; DEFAULT MODE NETWORK; DISEASE ASSOCIATION; HUMAN; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; RISK FACTOR; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE; SYNAPTIC TRANSMISSION; MEMORY CONSOLIDATION; MOLECULAR PATHOLOGY; PROTEIN AGGREGATION; PROTEIN FUNCTION; RISK ASSESSMENT; SLEEP; WAKEFULNESS; AGING; ANIMAL; BRAIN; COMPLICATION; DISEASE MODEL; METABOLISM; MOUSE; PHYSIOLOGY; PLAQUE, AMYLOID; RISK; SLEEP DISORDERED BREATHING;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; HUMANS; MICE; PLAQUE, AMYLOID; RISK; SLEEP; SLEEP APNEA SYNDROMES; SLEEP DISORDERS; WAKEFULNESS;

EID: 84903637801     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.03.035     Document Type: Review

References (57)

1. Alzheimer's Association, 2010. Changing the Trajectory of Alzheimer's Disease: A National Imperative, 2010. Accessed June 15,2013. http://www.alz.org/documents_custom/trajectory.pdf.
2. Ancoli-Israel S., Palmer B.W., Cooke J.R., Corey-Bloom J., Fiorentino L., Natarajan L., Liu L., Ayalon L., He F., Loredo J.S. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J.Am. Geriatr. Soc. 2008, 56:2076-2081.
3. Andreasen N., Hesse C., Davidsson P., Minthon L., Wallin A., Winblad B., Vanderstichele H., Vanmechelen E., Blennow K. Cerebrospinal fluid β-amyloid(1-42) in Alzheimer's disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch. Neurol. 1999, 56:673-680.
4. Bateman R.J., Wen G., Morris J.C., Holtzman D.M. Fluctuations of CSF amyloid-β levels: implications for a diagnostic and therapeutic biomarker. Neurology 2007, 68:666-669.
5. Bateman R.J., Xiong C., Benzinger T.L., Fagan A.M., Goate A., Fox N.C., Marcus D.S., Cairns N.J., Xie X., Blazey T.M., Holtzman D.M., Santacruz A., Buckles V., Oliver A., Moulder K., Aisen P.S., Ghetti B., Klunk W.E., McDade E., Martins R.N., Masters C.L., Mayeux R., Ringman J.M., Rossor M.N., Schofield P.R., Sperling R.A., Salloway S., Morris J.C. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N.Engl. J. Med. 2012, 367:795-804.
6. Bero A.W., Yan P., Roh J.H., Cirrito J.R., Stewart F.R., Raichle M.E., Lee J.M., Holtzman D.M. Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat. Neurosci. 2011, 14:750-756.
7. Blackwell T., Yaffe K., Ancoli-Israel S., Schneider J.L., Cauley J.A., Hillier T.A., Fink H.A., Stone K.L. Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J.Gerontol. A. Biol. Sci. Med. Sci. 2006, 61:405-410.
8. Blackwell T., Yaffe K., Ancoli-Israel S., Redline S., Ensrud K.E., Stefanick M.L., Laffan A., Stone K.L. Association of sleep characteristics and cognition in older community-dwelling men: the MrOS sleep study. Sleep 2011, 34:1347-1356.
9. Born J., Wilhelm I. System consolidation of memory during sleep. Psychol. Res. 2012, 76:192-203.
10. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
11. Brody D.L., Magnoni S., Schwetye K.E., Spinner M.L., Esparza T.J., Stocchetti N., Zipfel G.J., Holtzman D.M. Amyloid-β dynamics correlate with neurological status in the injured human brain. Science 2008, 321:1221-1224.
12. Buckner R.L. Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 2004, 44:195-208.
13. Buckner R.L., Snyder A.Z., Shannon B.J., LaRossa G., Sachs R., Fotenos A.F., Sheline Y.I., Klunk W.E., Mathis C.A., Morris J.C., Mintun M.A. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J.Neurosci. 2005, 25:7709-7717.
14. Cirrito J.R., Yamada K.A., Finn M.B., Sloviter R.S., Bales K.R., May P.C., Schoepp D.D., Paul S.M., Mennerick S., Holtzman D.M. Synaptic activity regulates interstitial fluid amyloid-β levels invivo. Neuron 2005, 48:913-922.
15. Cooke J.R., Ayalon L., Palmer B.W., Loredo J.S., Corey-Bloom J., Natarajan L., Liu L., Ancoli-Israel S. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J.Clin. Sleep Med. 2009, 5:305-309.
16. Faubel R., Lopez-Garcia E., Guallar-Castillon P., Graciani A., Banegas J.R., Rodriguez-Artalejo F. Usual sleep duration and cognitive function in older adults in Spain. J.Sleep Res. 2009, 18:427-435.
17. Ferrie J.E., Shipley M.J., Akbaraly T.N., Marmot M.G., Kivimaki M., Singh-Manoux A. Change in sleep duration and cognitive function: findings from the Whitehall II study. Sleep 2011, 34:565-573.
18. Greicius M.D., Srivastava G., Reiss A.L., Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl. Acad. Sci. U.S.A 2004, 101:4637-4642.
19. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
20. Huang Y., Potter R., Sigurdson W., Santacruz A., Shih S., Ju Y.-E., Kasten T., Morris J.C., Mintun M., Duntley S., Bateman R.J. Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system. Arch. Neurol. 2012, 69:51-58.
21. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
22. Jarrett J.T., Berger E.P., Lansbury P.T. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32:4693-4697.
23. Jonghe C.D., Cras P., Vanderstichele H., Cruts M., Vanderhoeven I., Smouts I., Vanmechelen E., Martin J.-J., Hendriks L., Broeckhoven C.V. Evidence that Abeta-42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype. Neurobiol. Dis. 1999, 6:280-287.
24. Jonsson T., Atwal J.K., Steinberg S., Snaedal J., Jonsson P.V., Bjornsson S., Stefansson H., Sulem P., Gudbjartsson D., Maloney J., Hoyte K., Gustafson A., Liu Y., Lu Y., Bhangale T., Graham R.R., Huttenlocher J., Bjornsdottir G., Andreassen O.A., Jonsson E.G., Palotie A., Behrens T.W., Magnusson O.T., Kong A., Thorsteinsdottir U., Watts R.J., Stefansson K. Amutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012, 488:96-99.
25. Ju Y.-E., McLeland J.S., Toedebusch C.D., Xiong C., Fagan A.M., Duntley S., Morris J.C., Holtzman D.M. Sleep quality and preclinical Alzheimer's disease. JAMA Neurol. 2013, 70:587-593.
26. Kanai M., Matsubara E., Isoe K., Urakami K., Nakashima K., Arai H., Sasaki H., Abe K., Iwatsubo T., Kosaka T., Watanabe M., Tomidokoro Y., Shizuka M., Mizushima K., Nakamura T., Igeta Y., Ikeda Y., Amari M., Kawarabayash i.T., Ishiguro K., Harigaya Y., Wakabayashi K., Okamoto K., Hirai S., Shoji M. Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease: a study in Japan. Ann. Neurol. 1998, 44:17-26.
27. Kang J.-E., Lim M.M., Bateman R.J., Lee J.J., Smyth L.P., Cirrito J.R., Fujiki N., Nishino S., Holtzman D.M. Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle. Science 2009, 326:1005-1007.
28. Keage H.A.D., Banks S., Yang K.L., Morgan K., Brayne C., Matthews F.E. What sleep characteristics predict cognitive decline in the elderly?. Sleep Med. 2012, 13:886-892.
29. Kronholm E., Sallinen M., Suutama T., Sulkava R., Era P., Partonen T. Self-reported sleep duration and cognitive functioning in the general population. J.Sleep Res. 2009, 18:436-446.
30. Lim A.S., Yu L., Costa M.D., Leurgans S.E., Buchman A.S., Bennett D.A., Saper C.B. Increased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individuals. Sleep 2012, 35:633-640.
31. Loerbroks A., Debling D., Amelang M., Sturmer T. Nocturnal sleep duration and cognitive impairment in a population-based study of older adults. Int. J. Geriatr. Psychiatry 2010, 25:100-109.
32. Mander B.A., Rao V., Lu B., Saletin J.M., Lindquist J.R., Ancoli-Israel S., Jagust W., Walker M.P. Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. Nat. Neurosci. 2013, 16:357-364.
33. Massimini M., Huber R., Ferrarelli F., Hill S., Tononi G. The slow wave oscillation as a traveling wave. J.Neurosci. 2004, 24:6862-6870.
34. Mayeux R., Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2:a006239.
35. McCurry S.M., Logsdon R.G., Teri L., Gibbons L.E., Kukull W.A., Bowen J.D., McCormick W.C., Larson E.B. Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients. J.Geriatr. Psychiatry Neurol. 1999, 12:53-59.
36. Meyer-Luehmann M., Stalder M., Herzig M.C., Kaeser S.A., Kohler E., Pfeifer M., Boncristiano S., Matthews P.M., Mercken M., Abramowski D., Staufenbiel M., Jucker M. Extracellular amyloid formation and associated pathology in neural grafts. Nat. Neurosci. 2003, 6:370-377.
37. 11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006, 67:446-452.
38. Morris J.C. Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics, Suppl 2005, 9-14.
39. Morris J.C., Roe C.M., Grant E.A., Head D., Storandt M., Goate A.M., Fagan A.M., Holtzman D.M., Mintun M.A. PIB imaging predicts progression from cognitively normal to symptomatic Alzheimer's disease. Arch. Neurol. 2009, 66:1469-1475.
40. Nir Y., Staba R.J., Andrillon T., Vyazovskiy V.V., Cirelli C., Fried I., Tononi G. Regional slow waves and spindles in human sleep. Neuron 2011, 70:153-169.
41. Potter R., Patterson B.W., Elbert D.L., Ovod V., Kasten T., Sigurdson W., Mawuenyega K., Blazey T., Goate A., Chott R., Yarasheski K.E., Holtzman D.M., Morris J.C., Benzinger T.L., Bateman R.J. Increased invivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers. Sci. Transl. Med. 2013, 5:189ra77.
42. Potvin O., Lorrain D., Forget H., Dube M., Grenier S., Preville M., Hudon C. Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults. Sleep 2012, 35:491-499.
43. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. Adefault mode of brain function. Proc. Natl. Acad. Sci. U.S.A 2000, 98:676-682.
44. Redline S., Kirchner H.L., Quan S.F., Gottlieb D.J., Kapur V., Newman A. The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture. Arch. Intern. Med. 2004, 164:406-418.
45. Roh J.H., Huang Y., Bero A.W., Kasten T., Stewart F.R., Bateman R.J., Holtzman D.M. Disruption of the sleep-wake cycle and diurnal fluctuation of amyloid-β in mice with Alzheimer's disease pathology. Sci. Transl. Med. 2012, 4:150ra22.
46. Samann P.G., Wehrle R., Hoehn D., Spoormaker V.I., Peters H., Tully C., Holsboer F., Czisch M. Development of the brain's default mode network from wakefulness to slow wave sleep. Cereb. Cortex 2011, 21:2082-2093.
47. Sowell E.R., Peterson B.S., Thompson P.M., Welcome S.E., Henkenius A.L., Toga A.W. Mapping cortical change across the human life span. Nat. Neurosci. 2003, 6:309-315.
48. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Kaye J., Montine T.J., Park D.C., Reiman E.M., Rowe C.C., Siemers E., Stern Y., Yaffe K., Carrillo M.C., Thies B., Morrison-Bogorad M., Wagster M.V., Phelps C.H. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute of Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011, 7:280-292.
49. Strooper B.D., Vassar R., Golde T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 2010, 6:99-107.
50. Tononi G., Cirelli C. Sleep function and synaptic homeostasis. Sleep Med. Rev. 2006, 10:49-62.
51. Tranah G.J., Blackwell T., Stone K.L., Ancoli-Israel S., Paudel M.L., Ensrud K.E., Cauley J.A., Redline S., Hillier T.A., Cummings S.R., Yaffe K. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann. Neurol. 2011, 70:722-732.
52. Tworoger S.S., Lee S., Schernhammer E.S., Grodstein F. The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer's Dis. Assoc. Disord. 2006, 20:41-48.
53. Vlassenko A.G., Vaishnavi S.N., Couture L., Sacco D., Shannon B.J., Mach R.H., Morris J.C., Raichle M.E., Mintun M.A. Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proc. Natl. Acad. Sci. U.S.A 2010, 107:17763-17767.
54. Vyazovskiy V.V., Olcese U., Hanlon E.C., Nir Y., Cirelli C., Tononi G. Local sleep in awake rats. Nature 2011, 472:443-447.
55. Xu L., Jiang C.Q., Lam T.H., Liu B., Jin Y.L., Zhu T., Zhang W.S., Cheng K.K., Thomas G.N. Short or long sleep duration is associated with memory impairment in older Chinese: the Guangzhou biobank cohort study. Sleep 2011, 34:575-580.
56. Yaffe K., Laffan A.M., Harrison S.L., Redline S., Spira A.P., Ensrud K.E., Ancoli-Israel S., Stone K.L. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011, 306:613-619.
57. Yesavage J.A., Friedman L., Ancoli-Israel S., Bliwise D., Singer C., Vitiello M.V., Monjan A.A., Lebowitz B. Development of criteria for defining sleepdisturbance in Alzheimer's disease. J.Geriatr. Psychiatry Neurol. 2003, 16:131-139.